Novel Tumor Growth Rate Analysis in the Randomized CLARINET Study Establishes the Efficacy of Lanreotide Depot/Autogel 120 mg with Prolonged Administration in Indolent Neuroendocrine Tumors

INTRODUCTION: Tumor quantity while receiving cancer therapy is the sum of simultaneous regression of treatment‐sensitive and growth of treatment‐resistant fractions at constant rates. Exponential rate constants for tumor regression/decay (d) and growth (g) can be estimated. Previous studies establis...

Descripción completa

Detalles Bibliográficos
Autores principales: Dromain, Clarisse, Loaiza‐Bonilla, Arturo, Mirakhur, Beloo, Beveridge, Thomas J.R., Fojo, Antonio Tito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Gastrointestinal Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018300/
https://www.ncbi.nlm.nih.gov/pubmed/33393112
http://dx.doi.org/10.1002/onco.13669

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018300/
https://www.ncbi.nlm.nih.gov/pubmed/33393112
http://dx.doi.org/10.1002/onco.13669

Ejemplares similares